Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.29

0.0%

Jan 8 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Machaon who wrote (27204)	1/5/1999 1:21:00 PM
From: Tommy D	of 32384

Sorry Bob but I think you are. The exercise of the warrants is recorded only on the balance sheet as an increase (or a credit) to share capital or equity and an increase in cash. It would only effect the income statement to the extent that some portion of the discount (or the imputed interest cost) was recorded as an expense. However, I would expect that this cost would be amortized over the remaining live of the warrants so would not be a charge on the 4th quarter. I want LGND to go up and I think the exercise is positive but don't expect it to effect the P&L statement for the quarter. Regards TommyD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next